163 related articles for article (PubMed ID: 27637748)
1. Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
Sun LH; Yang FQ; Zhang CB; Wu YP; Liang JS; Jin S; Wang Z; Wang HJ; Bao ZS; Yang ZX; Jiang T
CNS Neurosci Ther; 2017 Jan; 23(1):69-75. PubMed ID: 27637748
[TBL] [Abstract][Full Text] [Related]
2. Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.
Lv J; Yang H; Wang X; He R; Ding L; Sun X
Cancer Biomark; 2018; 22(2):311-316. PubMed ID: 29660900
[TBL] [Abstract][Full Text] [Related]
3. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
Wu DW; Cheng YW; Wang J; Chen CY; Lee H
Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
[TBL] [Abstract][Full Text] [Related]
4. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.
Chen Y; Zhao H; Xiao Y; Shen P; Tan L; Zhang S; Liu Q; Gao Z; Zhao J; Zhao Y; Guo Y; Feng Y
Aging (Albany NY); 2021 Jun; 13(12):16248-16266. PubMed ID: 34135128
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.
Chen DL; Wang ZQ; Ren C; Zeng ZL; Wang DS; Luo HY; Wang F; Qiu MZ; Bai L; Zhang DS; Wang FH; Li YH; Xu RH
J Transl Med; 2013 Nov; 11():277. PubMed ID: 24180516
[TBL] [Abstract][Full Text] [Related]
7. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
Li L; Wang J; Gao L; Gong L
Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
[TBL] [Abstract][Full Text] [Related]
8. Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis.
Huang Z; Wang H; Sun D; Liu J
Biomed Res Int; 2022; 2022():7171126. PubMed ID: 35782068
[TBL] [Abstract][Full Text] [Related]
9. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
10. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
11. Expression of CDC5L is associated with tumor progression in gliomas.
Chen W; Zhang L; Wang Y; Sun J; Wang D; Fan S; Ban N; Zhu J; Ji B; Wang Y
Tumour Biol; 2016 Mar; 37(3):4093-103. PubMed ID: 26490980
[TBL] [Abstract][Full Text] [Related]
12. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y
Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439
[TBL] [Abstract][Full Text] [Related]
13. The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.
Liu Q; Wang J; Tang M; Chen L; Qi X; Li J; Yu J; Qiu H; Wang Y
Future Oncol; 2018 Feb; 14(3):241-253. PubMed ID: 29318915
[TBL] [Abstract][Full Text] [Related]
14. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
15. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
[No Abstract] [Full Text] [Related]
16. KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.
Sun L; Zhang C; Yang Z; Wu Y; Wang H; Bao Z; Jiang T
Oncotarget; 2016 Apr; 7(17):24646-55. PubMed ID: 27013586
[TBL] [Abstract][Full Text] [Related]
17. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
Wang H; Jiang C
Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
[TBL] [Abstract][Full Text] [Related]
18. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
19. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
Bao Z; Zhang C; Yan W; Liu Y; Li M; Zhang W; Jiang T
J Transl Med; 2013 Apr; 11():100. PubMed ID: 23590708
[TBL] [Abstract][Full Text] [Related]
20. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
